FGEN News - Candlesense

FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference

SAN FRANCISCO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending and presenting at the H.C. Wainwright 27th Annual Global Investme...

Investor event

3 days ago

FibroGen Announces Approval of Sale of FibroGen China to AstraZeneca by the China State Administration for Market Regulation

SAN FRANCISCO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the China State Administration for Market Regulation approved the sale of FibroGen Internationa...

Will the divestiture impact FibroGen's pipeline and future revenue growth? What valuation did AstraZeneca pay for FibroGen China and how does it compare to similar deals? How will the sale affect FibroGen's cash flow and balance sheet?

Mergers

12 days ago

FibroGen Reports Second Quarter 2025 Financial Results and Provides Business Update

SAN FRANCISCO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today reported financial results for the second quarter 2025 and provided an update on the company’s recent developm...

Are there any red‑flag items or risks highlighted in the business update that warrant further scrutiny? What is the expected impact of the Q2 results on institutional and retail investor sentiment toward FGEN? How does the sentiment score of 10 reflect market perception, and could it lead to short‑term price volatility?

Earnings

19 days ago